Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Phase 1 Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

NCT04891965 is registered in ClinicalTrials.gov with Adiso Therapeutics as lead sponsor.

NCT NCT04891965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04891965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind, Phase 1 Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
Lead sponsor
Adiso Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
February 27, 2020
Completion date
October 13, 2022
Enrollment
36 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection recurrence